Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375109
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-04-16
Brief Title:
PD-L1PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
Sponsor:
Beijing Chest Hospital Capital Medical University
Organization:
Beijing Chest Hospital Capital Medical University
Organization Data
Organization:
Beijing Chest Hospital Capital Medical University
Class:
OTHER
Study ID:
BJXK-2023-KY-53
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Chest Hospital Capital Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Liang Shi MD
Responsible Party Title:
MDAssociate Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beijing Chest Hospital Capital Medical University
Old Name:
None
Old Organization:
None